FindTrial
Sign In

Qingchunbao Kang Shuai Lao Pian slows aging based on KDM biological age model

Qingchunbao Kang Shuai Lao Pian slows aging based on KDM biological age model

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500111865
Enrollment
Unknown
Registered
2025-11-06
Start date
2026-03-09
Completion date
Unknown
Last updated
2026-03-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biological aging

Interventions

Real-world study: recent and regular group (Took Qingchunbao Kang Shuai Lao Pian within the past six months regularly):None
Real-world study: recent and irregular group (Took Qingchunbao Kang Shuai Lao Pian within the past six months, but irregularly.):None
Real-world study: non-recent and regular group (No Qingchunbao Kang Shuai Lao Pian taken within the past six months
previously took it regularly.):None
Real-world study: non-recent and irregular group (No Qingchunbao Kang Shuai Lao Pian taken within the past six months
previously took it irregularly.):None
RCT study: Kang Shuai Lao Pian group:Take Qingchunbao Kang Shuai Lao Pian for one year.
RCT study: education group:Health education alone, without any other interventions.

Sponsors

School of Public Health, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1 Han Chinese ethnicity; 2 Age >= 18 years; 3 Willing to participate in the questionnaire survey, complete blood biochemical and routine blood tests, and provide the corresponding reports; 4 Provision of informed consent; 5 Long-term follow-up is possible (RCT study only).

Exclusion criteria

Exclusion criteria: 1 Unable to communicate effectively, with severe cognitive impairment and no qualified legal representative; 2 Undergoing cancer treatment, immunosuppressive therapy (e.g., cyclosporine, methotrexate, glucocorticoids), or anticoagulant therapy; or suffering from severe liver or kidney disease; 3 Currently taking other health supplements for 3 months or longer (e.g., NMN); 4 Individuals identified by a Traditional Chinese Medicine (TCM) constitution questionnaire as having Qi-depression or Yin-deficiency constitution and presenting with stage 2 or higher hypertension (SBP > 160 mmHg or DBP > 100 mmHg, RCT study only).

Design outcomes

Primary

MeasureTime frame
KDM biological age acceleration;—

Secondary

MeasureTime frame
Frailty Index;Traditional Chinese Medicine Syndrome;Pittsburgh Sleep Quality Index;Dietary patterns;—

Countries

China

Contacts

Public ContactZuyun Liu

School of Public Health, Zhejiang University

zuyunliu@zju.edu.cn+86 571 8707 7127

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026